WeVote
Log In

Bill

Bill

S 1420

Relates to the reimbursement rate for charter school facilities expansion in a city school district in a city having a population of one million or more inhabitants

2025 Regular Session Introduced by John Liu

Massachusetts nursing homes must publicly report psychotropic medication use, obtain informed consent, and face penalties for noncompliance to boost transparency and safety.

REFERRED TO NEW YORK CITY EDUCATION
0
WeVote Research Nonpartisan
Bill Summary · S 1420

Summary — S.1420 (2025): Administration of antipsychotic/psychotropic substances to nursing home residents

Note on document inconsistencies
- The package of metadata provided contains conflicting information (references to New York City committees, U.S. Senators as sponsors, and federal-sounding committee names). The bill text itself and the filing header indicate this is a Massachusetts state Senate bill filed in the One Hundred and Ninety-Fourth General Court (2025–2026) — Senate No. 1420 — concerning nursing home use of antipsychotic/psychotropic medications. This summary focuses on the statutory changes in the bill text. Verify final context and sponsor list on the Massachusetts General Court website.

Purpose and intent
- To strengthen oversight, transparency, and resident protections regarding the administration of antipsychotic and other psychotropic medications in Massachusetts nursing homes by clarifying terminology, requiring public reporting and disclosure, and creating enforceable penalties for noncompliance.

Statutory change (where)
- Amends Section 72BB of Chapter 111 of the Massachusetts General Laws (as appearing in the 2022 Official Edition).

Key provisions
1. Definition of “psychotropic”
- Adds a definition: “a psychotropic is any drug that affects brain activities associated with mental processes and behavior.”
- Lists primary categories: antipsychotics, antidepressants, anxiolytics, and depressants; permits inclusion of other drugs (e.g., anticonvulsants) when used for psychotropic purposes.

  1. Reporting requirements and enforcement

    • Failure to submit the Nursing Home (NH) Antipsychotic Medication Measures report (as required by Centers for Medicare & Medicaid Services) is declared a violation punishable by a monetary penalty set by the Department of Public Health.
    • Repeated or patterned failure to submit reports may lead to suspension of new admissions to the nursing home.

  2. Public posting of reports

    • Each quarterly NH Antipsychotic Medication Measures report must be prominently posted, at the time of submission, on both the Department of Public Health website and the respective nursing home’s website as public information.

  3. Care plan documentation and informed consent

    • Care plans for any resident administered a psychotropic must include:
      • Name and license number of the authorized prescriber;
      • Date of the evaluation documenting the need for the medication;
      • Reasons for prescribing the psychotropic;
      • Written certification that the resident or guardian (if any) has given informed consent.
    • The written consent declaration must be made under penalties of perjury.

Who would be affected
- Nursing homes operating in Massachusetts (administrative and compliance duties; potential penalties and admissions restrictions).
- Nursing home residents prescribed psychotropic medications and their families/guardians (greater transparency and formal informed consent).
- Prescribers (additional documentation requirements: name/license, documented evaluation and reasons).
- Massachusetts Department of Public Health (enforcement authority, rule-setting for penalties, website posting).

Potential impacts
- Increased transparency and public accountability for nursing home psychotropic medication use.
- Administrative and recordkeeping burdens on facilities and prescribers.
- Potential deterrence against inappropriate or undocumented psychotropic prescribing.
- Possible reputational and operational consequences for facilities that fail to comply (fines, admission suspensions).

Procedural and timeline notes (from provided materials)
- Bill filed January 16, 2025 (Senate docket). Petition signatures and dates appear in the filing.
- Various committee referrals and hearing notices were included in the provided materials but contain inconsistencies (different committees and dates). A hearing was listed for 10/14/2025 in the materials; confirm schedule with the official legislative calendar.

Recommendation
- Because of conflicting metadata, confirm bill status, sponsors, and committee actions directly via the Massachusetts General Court online docket for Senate No. 1420 before relying on the sponsor list or procedural history.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.